Epigral Limited (BOM:543332)

Market Cap	48.89B -36.3%
Revenue (ttm)	25.27B -0.9%
Net Income	3.32B -7.2%
EPS	76.95 -9.1%
Shares Out	n/a
PE Ratio	14.73
Forward PE	12.08
Dividend	5.00 (0.44%)
Ex-Dividend Date	Jun 1, 2026

Volume	829
Open	1,130.25
Previous Close	1,140.95
Day's Range	1,123.35 - 1,138.80
52-Week Range	806.20 - 2,114.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharm...

• Industry: Chemicals and Allied Products
• Founded: 2007
• Employees: 1,135
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543332

Financial Performance

In fiscal year 2026, Epigral's revenue was 25.27 billion, a decrease of -0.90% compared to the previous year's 25.50 billion. Earnings were 3.32 billion, a decrease of -7.19%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 22, 2026

Data Sources Report a data error